Efficacy of Rapamycin (Sirolimus) in the Treatment of Peutz-Jeghers Syndrome
Status:
Recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
A prospective non-randomized open label single arm clinical trial to examine the efficacy and
safety of sirolimus in patients with Peutz-Jeghers Syndrome.
Phase:
Phase 4
Details
Lead Sponsor:
Peking Union Medical College Hospital
Collaborators:
Air Force General Hospital of the PLA Chinese Academy of Medical Sciences Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences